JPMorgan Chase & Co’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.6M Sell
394,978
-26,533
-6% -$1.05M ﹤0.01% 1891
2025
Q1
$12.7M Buy
421,511
+5,592
+1% +$169K ﹤0.01% 2015
2024
Q4
$14.5M Sell
415,919
-152,987
-27% -$5.35M ﹤0.01% 1971
2024
Q3
$22.8M Sell
568,906
-25,185
-4% -$1.01M ﹤0.01% 1624
2024
Q2
$28.3M Sell
594,091
-36,888
-6% -$1.76M ﹤0.01% 1437
2024
Q1
$27.4M Sell
630,979
-310,053
-33% -$13.4M ﹤0.01% 1504
2023
Q4
$47.6M Buy
941,032
+39,975
+4% +$2.02M ﹤0.01% 1131
2023
Q3
$40.9M Sell
901,057
-166,666
-16% -$7.56M ﹤0.01% 1099
2023
Q2
$43.8M Buy
1,067,723
+10,328
+1% +$424K ﹤0.01% 1081
2023
Q1
$37.8M Buy
1,057,395
+87,085
+9% +$3.11M ﹤0.01% 1115
2022
Q4
$36.6M Buy
970,310
+41,558
+4% +$1.57M ﹤0.01% 1105
2022
Q3
$41.1M Sell
928,752
-110,818
-11% -$4.9M 0.01% 1035
2022
Q2
$38.5M Sell
1,039,570
-141,987
-12% -$5.26M 0.01% 1081
2022
Q1
$43.8M Sell
1,181,557
-87,095
-7% -$3.23M 0.01% 1118
2021
Q4
$38.6M Sell
1,268,652
-1,147,661
-47% -$34.9M ﹤0.01% 1202
2021
Q3
$81M Buy
2,416,313
+140,607
+6% +$4.72M 0.01% 897
2021
Q2
$90.8M Buy
2,275,706
+312,483
+16% +$12.5M 0.01% 882
2021
Q1
$88.3M Buy
1,963,223
+89,891
+5% +$4.04M 0.01% 843
2020
Q4
$106M Buy
1,873,332
+1,145,403
+157% +$64.8M 0.02% 701
2020
Q3
$35.3M Buy
727,929
+209,760
+40% +$10.2M 0.01% 1035
2020
Q2
$30.6M Buy
518,169
+246,447
+91% +$14.5M 0.01% 1021
2020
Q1
$12.8M Sell
271,722
-265,229
-49% -$12.5M ﹤0.01% 1393
2019
Q4
$32.4M Buy
536,951
+321,660
+149% +$19.4M 0.01% 1071
2019
Q3
$12.9M Buy
215,291
+36,553
+20% +$2.19M ﹤0.01% 1635
2019
Q2
$11.6M Buy
178,738
+166,696
+1,384% +$10.8M ﹤0.01% 1654
2019
Q1
$978K Sell
12,042
-136,616
-92% -$11.1M ﹤0.01% 3036
2018
Q4
$8.04M Buy
148,658
+138,181
+1,319% +$7.47M ﹤0.01% 1810
2018
Q3
$541K Sell
10,477
-1,037
-9% -$53.5K ﹤0.01% 3459
2018
Q2
$480K Buy
11,514
+6,058
+111% +$253K ﹤0.01% 3468
2018
Q1
$240K Sell
5,456
-56,651
-91% -$2.49M ﹤0.01% 3659
2017
Q4
$3.12M Sell
62,107
-465
-0.7% -$23.4K ﹤0.01% 2519
2017
Q3
$3.29M Buy
62,572
+60,763
+3,359% +$3.2M ﹤0.01% 2407
2017
Q2
$92K Buy
1,809
+894
+98% +$45.5K ﹤0.01% 3601
2017
Q1
$37K Sell
915
-360
-28% -$14.6K ﹤0.01% 3996
2016
Q4
$61K Sell
1,275
-3,543
-74% -$170K ﹤0.01% 3983
2016
Q3
$177K Sell
4,818
-43,141
-90% -$1.58M ﹤0.01% 3296
2016
Q2
$1.12M Buy
47,959
+39,420
+462% +$917K ﹤0.01% 2709
2016
Q1
$346K Buy
8,539
+6,539
+327% +$265K ﹤0.01% 3012
2015
Q4
$123K Sell
2,000
-9,822
-83% -$604K ﹤0.01% 3212
2015
Q3
$478K Sell
11,822
-30,279
-72% -$1.22M ﹤0.01% 2951
2015
Q2
$2.42M Sell
42,101
-302,805
-88% -$17.4M ﹤0.01% 2423
2015
Q1
$22M Sell
344,906
-21,400
-6% -$1.36M 0.01% 1263
2014
Q4
$22.6M Buy
366,306
+8,731
+2% +$539K 0.01% 1225
2014
Q3
$13.9M Buy
357,575
+94,258
+36% +$3.66M ﹤0.01% 1479
2014
Q2
$9.07M Sell
263,317
-93,232
-26% -$3.21M ﹤0.01% 1756
2014
Q1
$15.4M Buy
356,549
+341,761
+2,311% +$14.8M ﹤0.01% 1457
2013
Q4
$589K Sell
14,788
-44,325
-75% -$1.77M ﹤0.01% 3124
2013
Q3
$2.22M Sell
59,113
-50,890
-46% -$1.91M ﹤0.01% 2525
2013
Q2
$2.96M Buy
+110,003
New +$2.96M ﹤0.01% 2294